Sensitive liquid chromatography tandem mass spectrometry method for the quantification of Quetiapine in plasma

Biomed Chromatogr. 2008 Oct;22(10):1043-55. doi: 10.1002/bmc.1012.

Abstract

A sensitive high-performance liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of quetiapine in rat plasma. Following liquid-liquid extraction, the analyte was separated using a gradient mobile phase on a reverse-phase column and analyzed by MS/MS in the multiple reaction monitoring mode using the respective [M + H]+ ions, m/z 384 to m/z 221 for quetiapine and m/z 327 to m/z 270 for the internal standard. The assay exhibited a linear dynamic range of 0.25-500 ng/mL for quetiapine in rat plasma. The lower limit of quantification was 0.25 ng/mL with a relative standard deviation of less than 7%. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The validated method was successfully used to analyze rat plasma samples for application in pre-clinical pharmacokinetic studies. This method in rodent plasma could be adapted for quetiapine assay in human plasma.

Publication types

  • Validation Study

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Dibenzothiazepines / blood*
  • Quetiapine Fumarate
  • Rats
  • Rats, Wistar
  • Reproducibility of Results
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Tandem Mass Spectrometry / methods*

Substances

  • Dibenzothiazepines
  • Quetiapine Fumarate